日本動脈硬化学会.Japan Atherosclerosis Society (JAS)Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2012. URL: http://www.j-athero.org/en/publications/guideline2012.html.
Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study : primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987 ; 317: 1237.
Bezafibrate Infarction Prevention (BIP) study. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. Circulation 2000 ; 102: 21.
Keech A, Simes RJ, Barter P, et al ; FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005 ; 366 : 1849.